Sign in
4

Changes in Ownership

GALECTIN THERAPEUTICS INC Filed Acc 0001133416-24-000002

President and CEO acquired 11,606 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LEWIS JOEL · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-29 Grant or award : show line 1 in the form +11,606 $1.66 $19,266 1,042,300 D
Loading xslF345X05/form4.xml…